Galderma Aktie
92,79CHF | -0,93CHF | -0,99% |
WKN DE: GALD01 / ISIN: CH1335392721
Personal
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Personal am Ende des Jahres | 5 675 | 6 355 | 6 545 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,55 | 0,57 | 0,56 | 0,00 |
Bilanz (in Mio. CHF) - Aktiva
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Summe Umlaufvermögen | 1 382 | 1 394 | 1 360 | 1 670 |
Summe Anlagevermögen | 10 072 | 10 092 | 9 136 | 9 764 |
Summe Aktiva | 11 455 | 11 486 | 10 497 | 11 434 |
Bilanz (in Mio. CHF) - Passiva
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Summe Fremdkapital | 7 311 | 7 352 | 5 977 | 4 374 |
Summe Eigenkapital | 4 144 | 4 134 | 4 519 | 7 060 |
Summe Passiva | 11 455 | 11 486 | 10 497 | 11 434 |
Adresse
Zählerweg 10, 6300 Zug | |
Telefon | +41 (58) 455-85-92 |
Internet | http://www.galderma.com |
Management
Adrian Murphy
Head-Global Operations |
Allison Pinkham
Chief Human Resources Officer |
Emil Ivanov
Head-Strategy, Investor Relations & ESG |
Flemming Ørnskov
Chief Executive Officer & Director |
Karen L. Ling
Independent Director |
L. Daniel Browne
Independent Director |
Marcus Brennecke
Director |
Maria Teresa Hilado
Independent Director |
Michael Bauer
Director |
Sherilyn D. McCoy
Vice Chairman |
Thomas Ebeling
Chairman |
Thomas Johannes W. Dittrich
Chief Financial Officer |